BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1413536)

  • 1. [Epidemiology of HTLV-I].
    Tajima K; Ito S
    Uirusu; 1992 Jun; 42(1):49-57. PubMed ID: 1413536
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidemiology of adult T-cell leukemia and HTLV-1 infection--toward the eradication of HTLV-1 infectious diseases].
    Yamaguchi K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():32-6. PubMed ID: 23133924
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of mother-to-child transmission of human T-lymphotropic virus type-I.
    Tsuji Y; Doi H; Yamabe T; Ishimaru T; Miyamoto T; Hino S
    Pediatrics; 1990 Jul; 86(1):11-7. PubMed ID: 2359666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention of HTLV-1 in Japan.
    Hino S; Katamine S; Miyata H; Tsuji Y; Yamabe T; Miyamoto T
    Leukemia; 1997 Apr; 11 Suppl 3():57-9. PubMed ID: 9209297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decrease in mother-to-child transmission of human T lymphotropic virus type I (HTLV-I) in Okinawa, Japan.
    Kashiwagi K; Furusyo N; Nakashima H; Kubo N; Kinukawa N; Kashiwagi S; Hayashi J
    Am J Trop Med Hyg; 2004 Feb; 70(2):158-63. PubMed ID: 14993627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining trends in HTLV-I prevalence among blood donors in Japan.
    Yamaguchi K
    Intern Med; 2001 Jan; 40(1):1-2. PubMed ID: 11201361
    [No Abstract]   [Full Text] [Related]  

  • 7. [Viral infections in medicine. 2. The history of discovery and clinico-epidemiology of HTLV-I-associated myelopathy (HAM)].
    Osame M; Igata A
    Nihon Naika Gakkai Zasshi; 1988 Sep; 77(9):1343-6. PubMed ID: 3246550
    [No Abstract]   [Full Text] [Related]  

  • 8. [HIV-2 and HTLV-1/2 infections in Spain].
    TreviƱo A; Soriano V;
    Med Clin (Barc); 2010 Jun; 135(2):67-9. PubMed ID: 19560171
    [No Abstract]   [Full Text] [Related]  

  • 9. The incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan.
    Satake M; Yamada Y; Atogami S; Yamaguchi K
    Leuk Lymphoma; 2015 Jun; 56(6):1806-12. PubMed ID: 25219595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention of HTLV-I in Japan.
    Hino S; Katamine S; Miyata H; Tsuji Y; Yamabe T; Miyamoto T
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S199-203. PubMed ID: 8797724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to p40tax protein of human T cell leukemia virus 1 and infectivity.
    Kashiwagi S; Kajiyama W; Hayashi J; Noguchi A; Nakashima K; Nomura H; Ikematsu H; Sawada T; Kida S; Koide A
    J Infect Dis; 1990 Mar; 161(3):426-9. PubMed ID: 2313123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki.
    Chiyoda S; Kinoshita K; Egawa S; Inoue J; Watanabe K; Ifuku M
    Intern Med; 2001 Jan; 40(1):14-7. PubMed ID: 11201362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in HTLV-1 prevalence and incidence of adult T-cell leukemia/lymphoma in Nagasaki, Japan.
    Koga Y; Iwanaga M; Soda M; Inokuchi N; Sasaki D; Hasegawa H; Yanagihara K; Yamaguchi K; Kamihira S; Yamada Y
    J Med Virol; 2010 Apr; 82(4):668-74. PubMed ID: 20166187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of human T lymphotropic virus type 1 transmission in Okinawa, Japan.
    Kakuda K; Ikematsu H; Chong WL; Hayashi J; Kashiwagi S
    Am J Trop Med Hyg; 2002 Apr; 66(4):404-8. PubMed ID: 12164296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.
    Satake M; Yamaguchi K; Tadokoro K
    J Med Virol; 2012 Feb; 84(2):327-35. PubMed ID: 22170555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal viral infections.
    Ueda K; Tokugawa K; Kusuhara K
    Early Hum Dev; 1992; 29(1-3):131-5. PubMed ID: 1396225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HTLV-I carriers in ATL/L-nonendemic area--with reference to blood transfusions].
    Sakuma M; Takiguchi T; Konda S
    Nihon Ketsueki Gakkai Zasshi; 1989 Aug; 52(5):869-79. PubMed ID: 2588946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of HTLV-1 carrier in Japanese pregnant women.
    Suzuki S; Tanaka M; Matsuda H; Tsukahara Y; Kuribayashi Y; Gomibuchi H; Miyazaki R; Kamiya N; Nakai A; Kinoshita K;
    J Matern Fetal Neonatal Med; 2014 Feb; 27(3):312-3. PubMed ID: 23799916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seroprevalence of HTLV-I in various ocular diseases in central Japan].
    Goto K; Kurita M; Watanabe N; Ogi A; Iijima Y; Hanajiri M; Saeki K; Ohno S
    Nippon Ganka Gakkai Zasshi; 1995 Aug; 99(8):959-63. PubMed ID: 7676898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers?
    Arakaki T; Asato R; Ikeshiro T; Sakiyama K; Iwanaga M
    Trop Med Parasitol; 1992 Sep; 43(3):199-200. PubMed ID: 1470843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.